Balwinder Bhatti

Balwinder Bhatti is a master scientist specializing in medicinal and organic chemistry with over 12 years of experience at Targacept, Inc. Expertise includes leading drug discovery and development programs, with a strong focus on innovative solutions for novel small molecules. Prior to the current role, Balwinder served as a senior scientist at Targacept, contributing to discovery chemistry for neurodegenerative diseases and synthesizing novel nicotine-like compounds. Balwinder's academic background includes a Ph.D. in Organic Chemistry from Himachal Pradesh University and postdoctoral research at the University of Kentucky, where significant work involved synthesizing trans-3-hydroxycotinine and nicotine derivatives. Additional experience includes a research associate position at Roswell Park Cancer Institute.